Transaction · 0000947871-26-000980
ASPEAspen Neuroscience, Inc.
Orbimed Advisors LLC
ORBIMED ADVISORS LLC, DIR, reported an open-market or private purchase at Aspen Neuroscience, Inc. involving 1000000.000000 shares for an estimated $15000000.00. Reported holdings after the transaction were 3589132.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Open-market buySEC transaction code PDIR
- Trade date
- Nov 02, 2026
- Filing date
- Nov 04, 2026
How reported position traded is calculated
Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 2,589,132 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
ASPE price since this filing
Daily closing prices, with the filing date and available return windowsASPE · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y
Transaction facts
Stored Form 4 columns with their raw values
- Type
- Buy Code P
- Identifier
- 0000947871-26-000980 Common Stock
- Transaction date
- Nov 02, 2026 Filed Nov 04, 2026, 11:43 PM · 2d delay
- Shares
- 1,000,000 sh $15.00 per share
- Estimated value
- $15.0M Computed from shares × price
- Holdings after
- 3,589,132 sh Indirect · See footnotes
Filing signal explanations
Badges describe filing facts only — not predictions.
Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Buy Director Buy Large Buy Large Holdings Increase 10% Owner Buy
Filing-only score
+54 points
Compact filing score computed from stored Form 4 facts. Version v1.
Strong filing signal
This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.
How this score is calculated
- open_market_purchase+12 points
transaction_code = P
Code P is a discretionary open-market purchase. - director_buy+6 points
is_director = true
Director open-market purchase. - cluster_buy+14 points
cluster-buy signal matched
Multiple insiders bought within the configured window. - large_buy_absolute+10 points
large-buy signal with absolute_triggered = true
Open-market purchase exceeds the configured absolute threshold. - large_holdings_increase+8 points
large-holdings-increase signal matched
Reported acquired shares meet the configured percentage of post-transaction holdings. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Reported roles
No officer title
Officer NoDirector Yes10% YesOther No
Footnotes & amended
- F1
Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, as amended, each share of Series Seed-2 Convertible Preferred Stock, Series A-1 Convertible Preferred Stock, Series A-2 Conv…
- F2
Reflects shares of the Issuer's Common Stock purchased in the Issuer's initial public offering.
- F3
Securities held by OrbiMed Private Investments VII, LP ("OPI VII"). OrbiMed Capital GP VII LLC ("OrbiMed GP") is the general partner of OPI VII. OrbiMed Advisors LLC ("OrbiMed Advisors") is the managi…
- F4
This report on Form 4 is jointly filed by OrbiMed Advisors and OrbiMed GP. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a)…
Related transactions
Same SEC filing0 other transactions
Recent company activity
ASPE0 recent txs